Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MediciNova
AddedFeb 19, 2024
UpdatedJun 18, 2026
MediciNova

MediciNova

Public

US-based MediciNova develops small molecule therapeutics for various diseases, focusing on the US market.

HQ
Los Angeles, CA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Founded in La Jolla, United States, MediciNova, Inc. is a biopharmaceutical company dedicated to acquiring and developing small molecule therapeutics aimed at treating a range of diseases, including asthma, COPD, progressive multiple sclerosis, neuropathic pain, methamphetamine addiction, interstitial cystitis, and solid tumor cancers. The company's core mission is to provide innovative medical solutions that address unmet medical needs, primarily focusing on the healthcare market in the United States.

MediciNova has garnered attention for its impactful research and development efforts. Notable affiliated individuals include experts in the fields of neurology and pulmonology. The company has attracted significant investment from both private and institutional investors, enabling it to advance its clinical trials and expand its therapeutic pipeline. Key achievements include progressing several drug candidates through various stages of clinical trials, which has the potential to significantly impact patient care and treatment outcomes in its targeted disease areas.

MediciNova - Similar Companies

Traws Pharma logo

Traws Pharma

Medinox logo

Medinox

medinox.com

Link Medicine logo

Link Medicine

linksciences.com

NovelMed Therapeutics logo

NovelMed Therapeutics

novelmed.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Theravance Biopharma logo

Theravance Biopharma

theravance.com

MentiNova logo

MentiNova

NovoMedix logo

NovoMedix

novomedix.com

Novita Therapeutics logo

Novita Therapeutics

Mojave Pharma logo

Mojave Pharma

Ovid Therapeutics logo

Ovid Therapeutics

ovidrx.com

Evon Medics logo

Evon Medics

Nuon Therapeutics logo

Nuon Therapeutics

Minerva Neurosciences logo

Minerva Neurosciences

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

MediciNova - Quick Facts

Who are MediciNova's competitors?

Companies similar to MediciNova include Traws Pharma, Medinox, Link Medicine and NovelMed Therapeutics.

When was MediciNova founded?

MediciNova was founded in 2000.

Where is MediciNova's headquarters located?

MediciNova's headquarters is located in Los Angeles, CA, US.

When was MediciNova's last funding round?

MediciNova's most recent funding round was for $20M (USD) in January 2021.

How much has MediciNova raised to-date?

As of Jan 12, 2021, MediciNova has raised a total of $136M (USD).

How many employees does MediciNova have?

MediciNova has 13 employees as of Feb 6, 2024.

MediciNova - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 330927979
  • secCik: 0001226616
  • ticker: MNOV
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research